Zobrazit více v PubMed
Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos. Trends in Molecular Medicine. 2005;11:370.
PubMed
van Berkel MEAT, Oosterwegel MA. CD28 and ICOS: similar or separate costimulators of T cells? Immunology Letters. 2006;105:115.
PubMed
Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily. Trends in Biochemical Sciences. 2002;27:19.
PubMed
Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, Plebani A, Aiuti F, Quinti I. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. Journal of Allergy and Clinical Immunology. 2005;115:412.
PubMed
Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genetics. 2005a;37:829.
PubMed
Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. TACI and BAFF-R mediate isotype switching in B cells. Journal of Experimental Medicine. 2005b;201:35.
PubMed
PMC
Chtanova T, Tangye SG, Newton R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. Journal of Immunology. 2004;173:68.
PubMed
Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S. The CD 28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 2000;13:95.
PubMed
Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clinical and Experimental Medicine. 2004;3:211.
PubMed
de Durana YD, Mantchev GT, Bram RJ, Franco A. TACI-BlyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo. Blood. 2006;107:594.
PubMed
PMC
Grimbacher B, Hutloff A, Schlesier M. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nature Immunology. 2003;4:261.
PubMed
Grunig G, Banz A, de Waal Malefyt R. Molecular regulation of Th2 immunity by dendritic cells. Clinical Pharmacology and Therapeutics. 2005;106:75.
PubMed
Guzman VB, Morgun A, Shulzhenko N. Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups. Human Immunology. 2005;66:773.
PubMed
Haaning Andersen AD, Lange M, Lillevang ST. Allelic variation of the inducible costimulator (ICOS) gene: detection of polymorphisms, analysis of the promoter region, and extended haplotype estimation. Tissue Antigens. 2003;61:276.
PubMed
Harada Y, Ohgai D, Watanabe R, Okano K, Koiwai O, Tanabe K, Toma H, Altman A, Abe R. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS) Journal of Experimental Medicine. 2003;197:257.
PubMed
PMC
Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397:263.
PubMed
Itoh S, Itoh M, Nishida K, Yamasaki S, Yoshida Y, Narimatsu M, Park SJ, Hibi M, Ishihara K, Hirano T. Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. Journal of Immunology. 2002;168:5110.
PubMed
Janke M, Witsch EJ, Mages HW. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells. Immunology. 2006;118:353.
PubMed
PMC
Kroczek RA, Mages HW, Hutloff A. Emerging paradigms of T-cell co-stimulation. Current Opinion in Immunology. 2004;16:321.
PubMed
Litinskiy MB, Nardelli B, Hilbert DM. DCs induce CD40-independent immunoglobulin class switching through BlyS and APRIL. Nature Immunology. 2002;3:822.
PubMed
PMC
Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487.
PubMed
Löhning M, Hutloff A, Kallinich T. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. Journal of Experimental Medicine. 2003;197:181.
PubMed
PMC
Losi CG, Silini A, Fiorini C, Soresina A, Meini A, Ferrari S, Notarangelo LD, Lougaris V, Plebani A. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. Journal of Clinical Immunology. 2005;25:496.
PubMed
Mackay F, Ambrose Ch. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Reviews. 2003;14:311.
PubMed
Martin F, Vishva MD. Unraveling TACIt functions. Nature Genetics. 2005;37:793.
PubMed
McHeyzer-Williams MG. B cells as effectors. Current Opinion in Immunology. 2003;15:354.
PubMed
Novak AJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of B-lymphocyte stimulator by chronic lymphocytic leukemia cells: a mechanism for survival. Blood. 2002;100:2973.
PubMed
Ohm-Laursen L, Schjebel L, Jacobsen K. Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency. Scandinavian Journal of Immunology. 2005;61:566.
PubMed
Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debre P, Schmitt C, Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. Journal of Clinical Immunology. 2003;23:385.
PubMed
Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Current Opinion in Allergy and Clinical Immunology. 2005;5:496.
PubMed
Salzer U, Grimbacher B. Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation? Current Opinion in Rheumatology. 2006;18:377.
PubMed
Salzer U, Chapel HM, Webster ADB, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Genetics. 2005;37:820.
PubMed
Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, et al. ICOS deficiency in patients with common variable immunodeficiency. Clinical Immunology. 2004;113:234.
PubMed
Schejbel L, Marquart H, Andersen V, Permin H, Andersen P, Svejgaard A, Barington T. Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infections than lack of memory B cells in common variable immunodeficiency. Journal of Clinical Immunology. 2005;25:392.
PubMed
Schneider P, Tschopp J. BAFF and the regulation of B cell survival. Immunology Letters. 2003;88:57.
PubMed
Schneider P, Mackay F, Steiner V. BAFF, a novel ligand of the tumor necrosis factor (TNF) family, stimulates B cell growth. Journal of Experimental Medicine. 1999;189:1747.
PubMed
PMC
Seshasayee D, Valdez P, Yan M. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BlyS receptor. Immunity. 2003;18:279.
PubMed
Warnatz K, Bossaller L, Salzer U, Skrabl-Baumgartner A, Schwinger W, van der Burg M, van Dongen JJ, Orlowska-Volk M, Knoth R, Durandy A. Human ICOS-deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood. 2006;107:3045.
PubMed
Warnatz K, Denz A, Dräger R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH. Severe deficiency of switched memory B cells (CD27+IgM−IgD−) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99:1544.
PubMed
Weiler CR, Bankers-Fulbright JL. Common variable immunodeficiency: test indications and interpretations. Mayo Clinic Proceedings. 2005;80:1187.
PubMed
Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BlyS. Journal of Biological Chemistry. 2000;275:35478.
PubMed
van Zelm MC, Reisli I, van der Burg M. An antibody-deficiency syndrome due to mutations in the CD19 gene. New England Journal of Medicine. 2006;354:1901.
PubMed